Does a Defibrillator Restart a Stopped Heart?

A defibrillator does not restart a stopped heart. It does the opposite: it stops a heart that is beating in a dangerously chaotic rhythm. The confusion is one of the most widespread medical misconceptions in popular culture, reinforced by decades of television and film scenes showing paddles jolting a flatlined patient back to life. In reality, a flatline means no electrical activity at all, and shocking a heart in that state accomplishes nothing. A defibrillator works by delivering a controlled electrical shock that resets the heart’s electrical system during specific malfunctioning rhythms, giving the heart a chance to resume its normal beat on its own.

What a Defibrillator Actually Does

The heart’s pumping action depends on a tightly coordinated wave of electrical signals spreading across the muscle. During ventricular fibrillation, the most common rhythm treated by a defibrillator, that coordination collapses. Instead of beating in sync, individual muscle fibers quiver independently, and the heart moves no blood. The person loses consciousness within seconds and is clinically dead if nothing is done.

A defibrillation shock works by simultaneously depolarizing the heart muscle cells and extending their refractory period, the brief window after each electrical impulse during which a cell cannot fire again. Research in animal models showed that defibrillation-strength shocks prolong this depolarized, unresponsive state across the heart tissue, effectively silencing the chaotic signals all at once.¹ The effect is energy-dependent and timing-dependent: stronger shocks delivered later in the electrical cycle produce more refractory-period extension, creating a moment when no tissue is ready to propagate a wayward signal.² With all those chaotic wavefronts snuffed out simultaneously, the heart’s natural pacemaker cells have a clean slate to restart a normal rhythm from scratch.

So the shock is fundamentally a reset button. It does not pump the heart or generate a new heartbeat. It clears the electrical chaos so the heart’s own pacemaker can take over again. If the heart’s pacemaker cells are too damaged or too oxygen-starved to pick up the signal, the shock alone will not save the patient.

Why Hollywood Gets It Wrong

Films and television consistently show defibrillators being used on patients with a flatline, known medically as asystole. A study that analyzed defibrillation scenes in movies found that when the heart rhythm was identifiable on screen, the device was inappropriately used on asystole in about 39% of scenes, while it was correctly shown treating a shockable rhythm only 28% of the time.³ The dramatic arc of “shocking someone back from death” makes for compelling cinema, but it teaches audiences the exact wrong lesson about when defibrillation is useful.

Asystole is the absence of any electrical activity. There are no chaotic signals to terminate, so there is nothing for a defibrillator to do. The treatment for asystole is CPR, medications like epinephrine, and addressing whatever caused the heart to stop. A shock would be wasted and could even make things worse by stunning whatever marginal electrical activity might remain. Modern automated external defibrillators (AEDs) will not even allow a shock to be delivered in this situation, which is an important safety feature the movies never mention.

Shockable Versus Non-Shockable Rhythms

Cardiac arrest rhythms fall into two broad categories: shockable and non-shockable. Understanding the difference matters because it determines whether a defibrillator can help at all.

Ventricular fibrillation (VF): The classic shockable rhythm. The ventricles quiver uselessly. Defibrillation is the primary treatment.
Ventricular tachycardia (VT) without a pulse: The heart beats dangerously fast and cannot fill with blood between beats. Also shockable.
Asystole: No electrical activity at all. Not shockable. Treated with CPR and drugs.
Pulseless electrical activity (PEA): The heart generates electrical signals, but the muscle does not contract effectively enough to produce a pulse. Not shockable.

PEA is especially important because it can look on a monitor like the heart is doing something useful when it is not. Research has shown that in patients with severe pre-existing heart dysfunction, PEA can set in almost immediately after a coronary artery blockage, arriving far sooner than ventricular fibrillation would.⁴ When PEA is the initial rhythm, a defibrillator cannot help, and the patient’s survival depends entirely on CPR, medications, and identifying the underlying cause.

Every Minute Counts

For patients in ventricular fibrillation, the speed of defibrillation is arguably the single most important predictor of survival. A large study of over 3,700 patients with witnessed out-of-hospital cardiac arrests found that the chance of terminating VF with the first shock dropped from about 93% when the shock was delivered within six minutes to roughly 75% when it took longer than sixteen minutes.⁵ Each additional minute of delay was associated with a 6% higher probability of the shock failing to terminate VF and a 6% lower probability of the patient surviving to hospital discharge.

Separate research on patients who experienced recurrent episodes of VF during resuscitation found a similar pattern within the resuscitation itself: every extra minute spent in a shockable rhythm before the next shock was associated with roughly 19% lower odds of achieving return of spontaneous circulation.⁶ The biology behind this is straightforward: VF is metabolically expensive. The quivering heart burns through oxygen and energy stores rapidly, and the longer it fibrillates, the less likely the muscle is to resume coordinated pumping even after the electrical chaos is cleared.

CPR and Defibrillation Work Together

CPR and defibrillation are not competing treatments; they serve complementary roles. CPR provides a modest but critical trickle of blood flow to the heart and brain. It does not fix the rhythm, but it buys time by delivering enough oxygen to keep tissue alive until a defibrillator arrives. Without that blood flow, the heart muscle itself deteriorates, and the shock becomes less likely to work.

Animal research has demonstrated that maintaining adequate coronary perfusion pressure through CPR before defibrillation dramatically improves outcomes. In one study, animals that received hemodynamic-directed CPR targeting specific blood-pressure thresholds before shock had markedly higher short-term survival compared to those receiving standard protocols.⁷ The principle is consistent across studies: the quality of CPR in the minutes leading up to defibrillation profoundly affects whether the shock succeeds.

This is why resuscitation guidelines stress uninterrupted chest compressions. Pausing CPR to analyze the rhythm or charge the defibrillator means the coronary arteries go unperfused, and the window of opportunity narrows. Modern AEDs are designed to minimize these interruptions, with newer algorithms capable of analyzing heart rhythms even during ongoing chest compressions, achieving high accuracy in detecting shockable rhythms without requiring a pause.⁸

How AEDs Decide Whether to Shock

An automated external defibrillator does not trust a bystander to interpret heart rhythms. It analyzes the patient’s electrical activity on its own and makes the decision itself. The device applies adhesive electrode pads to the patient’s chest, reads the heart’s electrical signal, and runs it through an algorithm that classifies the rhythm as shockable or non-shockable. If the rhythm is shockable, the AED charges and either delivers the shock automatically or prompts the user to press a button.

These algorithms are highly accurate. One analysis of AED use in pediatric out-of-hospital cardiac arrests found the shock advisory system had a sensitivity of about 89% and a specificity above 99% for detecting shockable rhythms.⁹ Other algorithm designs have reported overall accuracy approaching 99%, with the ability to detect shockable rhythms in under a second.¹⁰ That high specificity is crucial: it means the device almost never shocks a rhythm that should not be shocked, which is what makes AEDs safe for untrained bystanders to use.

Bystander Defibrillation Saves Lives

The gap between “ambulance arrives” and “patient in VF” is often fatal, which is why placing AEDs in public spaces has become a major public health strategy. The data strongly supports it. A U.S. study of observed public cardiac arrests found that patients shocked by a bystander before paramedics arrived survived to hospital discharge at a rate of about 67%, compared with 43% for those who waited for EMS to deliver the first shock.¹¹ The odds of favorable neurological outcome were nearly three times higher with a bystander shock, and the benefit grew as ambulance response times increased.

A systematic review of public-access defibrillation programs worldwide found a median survival to hospital discharge of about 40% when AEDs were used by members of the public, with some programs reporting survival above 70%.¹² In Japan, where public AED placement has been pursued aggressively since the early 2000s, patients who received public-access defibrillation had roughly twice the odds of being alive at one month with good neurological function compared to those who did not.¹³

When the First Shock Does Not Work

Ventricular fibrillation that persists after three or more standard shocks is called refractory VF, and it presents one of the toughest challenges in resuscitation. The standard approach is to continue CPR, administer anti-arrhythmic drugs, and try again, but some patients remain in VF despite everything.

A newer approach called double sequential external defibrillation (DSED) uses two defibrillators positioned with their pads in different orientations, delivering rapid sequential shocks. The idea is that the two shocks, fired almost simultaneously from different vectors, can depolarize tissue that a single shock from one angle missed. The DOSE VF trial, a randomized controlled trial, compared DSED against standard defibrillation and vector-change defibrillation (simply repositioning the pads) in patients with refractory VF. Both DSED and vector change showed a significant increase in survival and favorable neurological outcome compared to standard shocks.¹⁴ A subsequent multistakeholder report identified DSED as a promising strategy warranting further study, and case reports have described its successful use even during extracorporeal CPR, a mechanical circulatory support technique used in the most extreme cases.¹⁵

Biphasic Versus Monophasic Waveforms

Not all defibrillation shocks are created equal. Older defibrillators used monophasic waveforms, sending current in a single direction through the heart. Modern devices use biphasic waveforms, which reverse the current partway through the shock. The practical difference is significant: biphasic shocks achieve the same success rate with much less energy.

A meta-analysis of randomized trials found that a 200-joule biphasic shock reduced the risk of persistent VF or post-shock asystole by roughly 81% compared to a 200-joule monophasic shock. Even when the biphasic energy was reduced to about 115-130 joules, it matched the effectiveness of the higher-energy monophasic shock, while producing less evidence of myocardial injury.¹⁶ Clinical trials of cardioversion for atrial fibrillation confirmed the trend: biphasic protocols reached 90% success using roughly half the cumulative energy of monophasic protocols.¹⁷

Less energy means less collateral damage. Research has shown that higher-energy shocks are associated with worse post-resuscitation heart function: the harder you hit the heart, the more stunned and dysfunctional it can be in the hours that follow, even after the rhythm is corrected.¹⁸ The shift to biphasic technology has been one of the quieter but most consequential advances in resuscitation science.

Defibrillation in Children

Cardiac arrest in children is far less common than in adults and less often caused by a shockable rhythm, but when VF does occur in a child, defibrillation is still the treatment. The challenge is dosing: a young child’s heart is smaller, and the standard adult energy level can cause unnecessary myocardial damage.

The traditional recommended dose for pediatric defibrillation has been 2 joules per kilogram of body weight, though some guidelines have moved toward a higher initial dose of 4 joules per kilogram.¹⁹ Standard adult AEDs in public spaces can be adapted for children using special pediatric pads or a cable system that attenuates the energy output. Animal studies have shown that unattenuated adult-dose shocks cause greater myocardial damage and worse post-resuscitation heart function compared to pediatric-attenuated doses, supporting the use of reduced-energy pads when available.²⁰ However, the consensus in emergency medicine is clear: if a child is in cardiac arrest and only an adult AED is available, use it. An imperfectly dosed shock is vastly better than no shock at all.

From Operating Rooms to Airport Terminals

The history of defibrillation helps explain why the “restart the heart” myth took hold. In 1947, the first successful human defibrillation was performed with the chest surgically open and electrodes placed directly on the exposed heart. Ten years later came the first closed-chest defibrillator, a 120-kilogram machine that delivered 500 volts of alternating current and could only be used in hospital surgical suites. By 1956, a wheeled version appeared, and by the early 1960s, the switch from alternating current to direct current reduced the risk of additional heart damage.²¹

From there the technology moved outward in waves: into coronary care units, then emergency departments, then mobile ambulances in the late 1960s, then paramedic units in the early 1970s. The first implantable cardioverter-defibrillator arrived in 1980, and automated external defibrillators for use by the general public appeared in the late 1980s. Each step was controversial at the time, with skeptics questioning whether non-physicians could safely deliver electrical shocks. The AED resolved that debate by making the decision for the user, analyzing the rhythm and refusing to shock unless the algorithm confirmed a shockable pattern.

Implantable Defibrillators and Continuous Monitoring

For people at high risk of sudden cardiac arrest, such as those with inherited heart conditions or severely weakened heart muscle, an implantable cardioverter-defibrillator (ICD) provides around-the-clock protection. The device, roughly the size of a small matchbox, sits under the skin near the collarbone with leads threaded into the heart. It continuously monitors the heart’s electrical activity using rate-based detection algorithms and electrogram analysis, looking for dangerous rhythms.²²

When the ICD detects ventricular fibrillation or dangerously fast ventricular tachycardia, it delivers a shock internally, directly to the heart muscle, within seconds of onset. Because the shock is delivered from inside the chest rather than through the chest wall, far less energy is needed. Some patients describe the experience as a sudden kick or jolt in the chest. The device can also deliver anti-tachycardia pacing, a series of rapid but gentle pacing pulses that can terminate certain fast rhythms without a full shock, which patients typically do not feel at all. The key advantage of an ICD is time: it eliminates the minutes-long delay that makes out-of-hospital cardiac arrest so lethal, delivering therapy in the window when the heart’s chances of responding are highest.